Paeoniflorin Curbs Obesity in Mice Study
A peer-reviewed study in C57BL/6 mice reports that the plant compound paeoniflorin reduced high-fat diet-induced weight gain and metabolic markers.
Updated on Nov. 14, 2026 in Weight Loss

Researchers reported in Scientific Reports that oral paeoniflorin at 100 or 200 mg/kg reduced final body weight and improved fasting glucose and insulin in high-fat diet-fed mice. The study was published as an accepted early-access article on November 14, 2026.
Why it matters
The findings add experimental evidence that paeoniflorin may influence fat tissue metabolism through AMPK and SIRT3 signaling. The results come from animal and cell models, so they do not show whether the compound would have similar effects in people.
The study is an animal and cell-based experiment, with body weight down 5.6% at 100 mg/kg and 9.8% at 200 mg/kg versus high-fat diet controls. Human effects, long-term safety and translation to other populations remain unknown.
The players
Scientific Reports
An open-access, peer-reviewed journal published by Nature Portfolio that covers natural sciences and medicine.
The details
Researchers fed C57BL/6 mice a high-fat diet to induce obesity and then gave paeoniflorin orally at 100 or 200 mg/kg. The compound reduced adipocyte hypertrophy, increased thermogenic markers UCP1, PGC-1α and PRDM16 in inguinal white adipose tissue, and in 3T3-L1 adipocytes activated AMPK/SIRT3 signaling; blocking AMPK weakened its effects.
Timeline
November 14, 2026: study published as an accepted early-access article in Scientific Reports.
Health Landscape
The work follows a line of preclinical research into AMPK-driven browning and thermogenesis in white fat, as seen in studies of UCP1 and PGC-1α regulation. Its results remain confined to rodent and cell models, so it is an early step rather than evidence of a treatment shift.
Readers should not treat paeoniflorin as a weight-loss option, since the evidence comes only from mice and cell cultures. Any change to diet, supplements or medication for weight should be discussed with a licensed clinician.
The takeaway
Experimental results in animals and cells suggest paeoniflorin can affect fat metabolism through AMPK signaling. Human trials would be needed before any conclusions about weight management in people.
Further reading
Explore more research on Weight Loss approaches and how they are tested.
More information
Read the full peer-reviewed study DOI record in Scientific Reports.
Source note: This article includes information reported by Nature.



